Tabrecta

Indicated For

MET NSCLC

About This Medication

# Novartis Patient Assistance Foundation Patient Guide: How to Get Tabrecta (capmatinib) at Low or No Cost Tabrecta (capmatinib) is a targeted therapy medication used to treat adults with a specific type of **non-small cell lung cancer (NSCLC)** that has a mutation in the MET gene called exon 14 skipping, when the cancer has spread or cannot be removed by surgery. This guide explains how the **Novartis Patient Assistance Foundation (NPAF)** program can help eligible patients get **Tabrecta** for free or at very low cost if you face financial challenges.[1][2] ## About Tabrecta (capmatinib) **Tabrecta** is an oral tablet taken twice daily, prescribed for patients with **MET exon 14 skipping-altered metastatic NSCLC**. It works by blocking proteins that help cancer cells grow, helping to slow or stop cancer progression. Common side effects include lung, liver, or kidney problems, nausea, vomiting, diarrhea, and fatigue—always discuss risks with your healthcare provider (HCP). It's typically used when other treatments aren't suitable. Without insurance or assistance, Tabrecta can cost tens of thousands of dollars per month, making programs like NPAF essential for access.[1][3] ## Who Qualifies for the NPAF Program? The NPAF helps U.S. residents (including territories) who: - Have **limited or no prescription insurance coverage**. - Meet **income guidelines** (vary by product like Tabrecta, household size, and state; higher in Alaska/Hawaii). - Have a **valid prescription** from a licensed U.S. HCP for outpatient treatment. You don't need to be completely uninsured—some insured patients qualify if they can't afford copays or face denials. Medicare Part D **Extra Help** denial proof may be needed, but Medicare/Medicaid patients can sometimes qualify through NPAF.[1][2][3][5] ## Income Eligibility Breakdown NPAF income limits are based on **Federal Poverty Level (FPL)** percentages, adjusted for **household size** (from your tax return) and location. Exact thresholds for **Tabrecta** aren't fixed publicly and vary—**check www.PAP.Novartis.com** for your medication's specifics.[2][3] Here's a general example table (based on typical PAP guidelines; confirm current FPL at PAP.Novartis.com as they update yearly): | Household Size | Continental U.S. (e.g., 400-500% FPL) | Alaska (Higher Limits) | Hawaii (Higher Limits) | |---------------|---------------------------------------|-------------------------|-------------------------| | 1 (Individual)| ~$60,000 | ~$75,000 | ~$69,000 | | 2 (Couple) | ~$81,000 | ~$101,000 | ~$93,000 | | 3 | ~$102,000 | ~$128,000 | ~$117,000 | | 4 | ~$123,000 | ~$154,000 | ~$141,000 | *Notes: Add ~$21,000 per extra person in continental U.S. Proof: First 2 pages of recent **1040 tax return**. No taxes filed? Call 1-800-277-2254.[1][2][5] Always verify exact Tabrecta limits online or by phone, as they differ by drug.[3] ## Insurance Requirements - **Uninsured** patients qualify easily if income-eligible. - **Insured** (including Medicare/Medicaid): Submit **front/back copies of all insurance cards** (primary, secondary, Rx). Include **Prior Authorization (PA) denial** or appeal outcomes if required by insurance.[1][2] - Medicare patients denied **Extra Help** must provide denial proof. - NPAF covers patients who can't afford out-of-pocket costs despite coverage.[3][5] ## Step-by-Step Application Process 1. **Check Eligibility**: Visit **www.PAP.Novartis.com**, enter **Tabrecta** to confirm income limits and guidelines.[2][3][5] 2. **Download Form**: Get the application from PAP.Novartis.com or call 1-800-277-2254 (Mon-Fri, 9am-6pm EST).[3][4] 3. **Gather Documents**: - **Proof of income**: First 2 pages of latest **1040 tax return** (or contact NPAF if not filing).[1][2][5] - **Proof of Extra Help denial** (if applicable).[1] - **HCP prescription** (original or signed Rx section).[4][7] - **Insurance cards** (front/back, all types).[1][2] 4. **Complete Application**: - **Patient section**: Personal info, income, household size, insurance, signature, and date.[1][10] - **HCP section**: Doctor completes treatment details, signs Rx and authorization.[4] 5. **Submit**: **Fax** to 1-855-817-2711 **OR mail** to NPAF, PO Box 2529, Columbus, OH 43216 (or current address like Phoenix, AZ—check form).[1][2][5] **Tip**: Incomplete apps delay or deny—double-check everything![1][2][4] ## Timeline and Delivery - **Processing**: Up to **4 weeks** for a decision letter (or text if opted in).[3][5] - If approved, **Tabrecta** ships **directly to you** (your home or pharmacy).[1] - Annual **reauthorization** required—resubmit yearly.[9] ## Alternatives if Denied - **Appeal**: Review denial letter for reasons (e.g., income too high); gather more docs and resubmit.[3][6] - **Other Novartis Programs**: Check PAP.Novartis.com for copay cards or bridge programs.[2] - **General Resources**: NeedyMeds.org, RxAssist.org, or state programs. - **Manufacturer Contact**: Call Novartis at 1-800-277-2254 for guidance.[3][5] - **No biosimilars** for Tabrecta currently.[1] ## Important Disclaimer This guide is for informational purposes only and based on publicly available NPAF details as of latest updates. **Eligibility, income limits, addresses, and processes can change**—always verify at **www.PAP.Novartis.com** or call 1-800-277-2254. NPAF decisions are final; this isn't medical/financial advice. Consult your HCP for treatment options. Novartis doesn't guarantee approval. Word count: ~950.

Program information last verified: March 30, 2026